Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Genome Informatics. Workshop on Genome Informatics
|
November 9, 2001
An infrastructure for comparative genomics to functionally characterize genes and proteins
C Suter-Crazzolara, G Kurapkat
Protein Science : a Publication of the Protein Society
|
March 1, 1997
Inactive conformation of an insulin despite its wild-type sequence
G Kurapkat, E De Wolf, J Grötzinger, et al.
Proteins
|
January 1, 1997
The family of the IL-6-type cytokines: specificity and promiscuity of the receptor complexes
J Grötzinger, G Kurapkat, A Wollmer, et al.
Protein Science : a Publication of the Protein Society
|
March 26, 1999
The solution structure of a superpotent B-chain-shortened single-replacement insulin analogue
G Kurapkat, M Siedentop, H G Gattner, et al.
Biopolymers
|
March 1, 1997
Calculations of the CD spectrum of bovine pancreatic ribonuclease
G Kurapkat, P Krüger, A Wollmer, et al.
The Biochemical Journal
|
July 1, 1995
Human ciliary neurotrophic factor: a structure-function analysis
A Krüttgen, J Grötzinger, G Kurapkat, et al.
Protein Science : a Publication of the Protein Society
|
April 21, 1999
The signal transducer gp130: solution structure of the carboxy-terminal domain of the cytokine receptor homology region
T Kernebeck, S Pflanz, G Müller-Newen, et al.
FEBS Letters
|
August 7, 1995
Leucine-58 in the putative 5th helical region of human interleukin (IL)-6 is important for activation of the IL-6 signal transducer, gp130
F D de Hon, H K Klaasse Bos, S B Ebeling, et al.
The Journal of Biological Chemistry
|
May 31, 1996
Differential activation of acute phase response factor/Stat3 and Stat1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. II. Src homology SH2 domains define the specificity of stat factor activation
U Hemmann, C Gerhartz, B Heesel, et al.
The Journal of Biological Chemistry
|
April 7, 1995
Combining two mutations of human interleukin-6 that affect gp130 activation results in a potent interleukin-6 receptor antagonist on human myeloma cells
M Ehlers, F D de Hon, H K Bos, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Genome Informatics. Workshop on Genome Informatics
|
November 9, 2001
An infrastructure for comparative genomics to functionally characterize genes and proteins
C Suter-Crazzolara, G Kurapkat
Protein Science : a Publication of the Protein Society
|
March 1, 1997
Inactive conformation of an insulin despite its wild-type sequence
G Kurapkat, E De Wolf, J Grötzinger, et al.
Proteins
|
January 1, 1997
The family of the IL-6-type cytokines: specificity and promiscuity of the receptor complexes
J Grötzinger, G Kurapkat, A Wollmer, et al.
Protein Science : a Publication of the Protein Society
|
March 26, 1999
The solution structure of a superpotent B-chain-shortened single-replacement insulin analogue
G Kurapkat, M Siedentop, H G Gattner, et al.
Biopolymers
|
March 1, 1997
Calculations of the CD spectrum of bovine pancreatic ribonuclease
G Kurapkat, P Krüger, A Wollmer, et al.
The Biochemical Journal
|
July 1, 1995
Human ciliary neurotrophic factor: a structure-function analysis
A Krüttgen, J Grötzinger, G Kurapkat, et al.
Protein Science : a Publication of the Protein Society
|
April 21, 1999
The signal transducer gp130: solution structure of the carboxy-terminal domain of the cytokine receptor homology region
T Kernebeck, S Pflanz, G Müller-Newen, et al.
FEBS Letters
|
August 7, 1995
Leucine-58 in the putative 5th helical region of human interleukin (IL)-6 is important for activation of the IL-6 signal transducer, gp130
F D de Hon, H K Klaasse Bos, S B Ebeling, et al.
The Journal of Biological Chemistry
|
May 31, 1996
Differential activation of acute phase response factor/Stat3 and Stat1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. II. Src homology SH2 domains define the specificity of stat factor activation
U Hemmann, C Gerhartz, B Heesel, et al.
The Journal of Biological Chemistry
|
April 7, 1995
Combining two mutations of human interleukin-6 that affect gp130 activation results in a potent interleukin-6 receptor antagonist on human myeloma cells
M Ehlers, F D de Hon, H K Bos, et al.
Page
of 2